Larvol Delta - A-Phase-IbII-Study-to-Evaluate-the-Safety-Tolerability-and-Efficacy-of-IMD303-in-Participants-With-Advanced-Malignant-Solid-Tumors

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

IMD303 - Affinity Biopharma

https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12626000450314

Apr 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next